Thomas Reiberger Selected Research

Lipids

9/2019	Patterns and prevalence of dyslipidemia in patients with different etiologies of chronic liver disease.
1/2019	Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation.
2/2018	Impact of glutathione peroxidase 4 on cell proliferation, angiogenesis and cytokine production in hepatocellular carcinoma.
3/2017	The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Reiberger Research Topics

Disease

95	Fibrosis (Cirrhosis) 04/2024 - 01/2008
75	Liver Diseases (Liver Disease) 03/2024 - 01/2015
68	Portal Hypertension 03/2024 - 07/2011
32	Liver Cirrhosis (Hepatic Cirrhosis) 03/2024 - 06/2012
25	Infections 03/2024 - 07/2011
25	Hemorrhage 02/2024 - 11/2013
24	Inflammation (Inflammations) 01/2024 - 01/2008
24	Hepatocellular Carcinoma (Hepatoma) 08/2023 - 04/2014
21	Ascites 02/2024 - 01/2014
17	End Stage Liver Disease 08/2023 - 01/2017
12	Hepatitis C 03/2024 - 01/2013
11	Varicose Veins (Varicose Vein) 03/2024 - 11/2013
11	Disease Progression 06/2023 - 09/2019
9	Non-alcoholic Fatty Liver Disease 08/2023 - 03/2017
9	Coinfection 01/2023 - 07/2010
8	Hepatic Encephalopathy 04/2024 - 01/2018
8	Acute-On-Chronic Liver Failure 01/2024 - 10/2017
8	Neoplasms (Cancer) 01/2021 - 04/2014
7	Thrombosis (Thrombus) 12/2023 - 07/2018
6	COVID-19 12/2022 - 01/2021
6	Chronic Hepatitis C 01/2021 - 01/2013
5	Cholestasis 11/2023 - 02/2015
4	Chronic Hepatitis D 03/2024 - 01/2022
4	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 02/2024 - 12/2020
4	Chronic Hepatitis B 01/2023 - 01/2012
4	Anemia 12/2022 - 07/2011
4	Fatty Liver 01/2020 - 01/2018
4	Hypertension (High Blood Pressure) 09/2019 - 01/2017
3	Hepatitis 01/2024 - 01/2013
3	Bacterial Infections (Bacterial Infection) 12/2023 - 01/2021
3	Viremia 09/2023 - 01/2020
3	Alcoholic Liver Diseases (Alcoholic Liver Disease) 07/2023 - 01/2021
3	Hepatitis B 04/2023 - 01/2013
3	Critical Illness (Critically Ill) 01/2023 - 11/2017
3	Sepsis (Septicemia) 05/2021 - 11/2017
3	Acquired Immunodeficiency Syndrome (AIDS) 11/2013 - 08/2012
2	Thromboembolism 12/2023 - 10/2020
2	Hyperbilirubinemia 11/2023 - 01/2023
2	Hyponatremia 10/2023 - 05/2021

Drug/Important Bio-Agent (IBA)

26	4-(3-chlorophenylsulfanyl)piperidineIBA 03/2024 - 07/2011
19	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2014
19	Antiviral Agents (Antivirals)IBA 03/2024 - 01/2008
15	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2011
15	AlbuminsIBA 10/2023 - 01/2018
15	InterferonsIBA 04/2022 - 01/2008
14	von Willebrand FactorIBA 03/2024 - 10/2012
13	C-Reactive ProteinIBA 01/2024 - 01/2018
9	BilirubinIBA 02/2024 - 12/2019
8	AntigensIBA 01/2024 - 10/2012
8	CreatinineIBA 10/2023 - 11/2015
8	SodiumIBA 10/2023 - 09/2015
8	Ribavirin (Virazole)FDA LinkGeneric 03/2018 - 07/2010
7	Propranolol (Inderal)FDA LinkGeneric 01/2023 - 11/2013
7	Proteins (Proteins, Gene)FDA Link 08/2022 - 01/2008
7	Alanine Transaminase (SGPT)IBA 01/2019 - 01/2008
6	AmmoniaIBA 04/2024 - 02/2021
6	bulevirtideIBA 03/2024 - 01/2022
6	Interleukin-6 (Interleukin 6)IBA 08/2023 - 05/2013
6	gadolinium ethoxybenzyl DTPA FDA Link 02/2023 - 01/2017
6	Carvedilol (Coreg)FDA LinkGeneric 01/2023 - 11/2013
5	Transaminases (Aminotransferases)IBA 03/2024 - 02/2015
5	Bile Acids and Salts (Bile Acids)IBA 11/2023 - 01/2017
5	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 11/2009
4	CollagenIBA 03/2024 - 04/2014
4	Immunoglobulin M (IgM)IBA 05/2023 - 02/2021
4	Thrombin FDA Link 01/2023 - 01/2022
4	Bevacizumab (Avastin)FDA Link 01/2023 - 12/2015
4	Messenger RNA (mRNA)IBA 12/2022 - 11/2009
4	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2022 - 08/2015
4	LipidsIBA 09/2019 - 03/2017
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019 - 01/2015
3	DiureticsIBA 02/2024 - 01/2018
3	Soluble Guanylyl CyclaseIBA 11/2023 - 12/2020
3	Cytidine Triphosphate (CTP)IBA 10/2023 - 12/2019
3	ProcalcitoninIBA 05/2023 - 01/2021
3	Immunoglobulin A (IgA)IBA 05/2023 - 05/2013
3	Immunoglobulin G (IgG)IBA 05/2023 - 05/2013
3	Immune Checkpoint InhibitorsIBA 01/2023 - 05/2015
3	TransferasesIBA 01/2023 - 01/2019
3	AnticoagulantsIBA 01/2023 - 07/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2021
3	atezolizumabIBA 01/2023 - 01/2022
3	ReninIBA 12/2021 - 01/2017
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2021 - 01/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 05/2016
3	Polytetrafluoroethylene (Teflon)FDA Link 01/2018 - 12/2017
3	InterleukinsIBA 03/2015 - 07/2011
2	CytokinesIBA 05/2024 - 02/2018
2	Alkaline PhosphataseIBA 02/2024 - 12/2022
2	Epinephrine (Adrenaline)FDA LinkGeneric 12/2023 - 08/2022

Therapy/Procedure

43	Therapeutics 02/2024 - 01/2008
24	Liver Transplantation 10/2023 - 03/2017
14	Transjugular Intrahepatic Portasystemic Shunt 10/2023 - 09/2017
13	Surgical Portasystemic Shunt (Portosystemic Shunt) 02/2024 - 12/2017
13	Ligation 11/2023 - 11/2013
6	Immunotherapy 10/2023 - 05/2015
4	Stents 08/2022 - 12/2017
3	Contraindications 10/2023 - 05/2014
3	Art Therapy 08/2023 - 01/2016
3	Transplantation 01/2023 - 10/2012